Gender‐dependent pharmacokinetics of olaparib in rats determined by ultra‐high performance liquid chromatography/electrospray ionization tandem mass spectrometry
Authors:
- 3 January 2020
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 34 (3) , e4791
Abstract
The aim of the present study was to develop a liquid chromatography/electrospray ionization tandem mass spectrometry (LC–ESI–MS/MS) method for the determination of olaparib in rat plasma. The plasma samples were processed using one‐step protein precipitation with acetonitrile and then separated on Waters Acquity BEH C18 column (50 × 2.1 mm, particle size 1.7 μm) using water containing 0.1% formic acid and acetonitrile as mobile phase with optimized gradient elution. Mass spectrometric detection was carried out by selective reaction monitoring mode via positive ESI mode with precursor‐to‐product transitions of m/z 435.3 > 367.1 and m/z 443.1 > 375.2 for olaparib and 2H8‐olaparib (internal standard). The method was linear over the concentration range 0.1–2000 ng/ml with correlation coefficient >0.9987. The lower limit of quantitation was 0.1 ng/ml. The method showed excellent accuracy and precision, negligible matrix effect and high extraction recovery. The validated method was subsequently utilized to determine the concentration of olaparib in rat plasma and further applied to the pharmacokinetic study of olaparib in rat plasma. Our results demonstrated that olaparib showed gender‐dependent pharmacokinetics in rats. Compared with that in males, olaparib showed high plasma exposure, long half‐life, low clearance and high bioavailability in females.Keywords
This publication has 17 references indexed in Scilit:
- Current status of poly(ADP-ribose) polymerase inhibitors and future directionsOncoTargets and Therapy, 2017
- Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometryJournal of Ethnopharmacology, 2013
- Sex dependent pharmacokinetics, tissue distribution and excretion of peimine and peiminine in rats assessed by liquid chromatography–tandem mass spectrometryJournal of Ethnopharmacology, 2013
- Sensitive and robust UPLC–MS/MS method to determine the gender-dependent pharmacokinetics in rats of emodin and its glucuronideJournal of Pharmaceutical and Biomedical Analysis, 2011
- 4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1Journal of Medicinal Chemistry, 2008
- Intestinal Expression and Metabolic Activity of the CYP3A Subfamily in Female RatsBiological and Pharmaceutical Bulletin, 2005
- How Important Are Gender Differences in Pharmacokinetics?Clinical Pharmacokinetics, 2002
- Base Excision Repair Is Impaired in Mammalian Cells Lacking Poly(ADP-ribose) Polymerase-1Biochemistry, 2000
- Gender‐Related Differences in Xenobiotic MetabolismThe Journal of Clinical Pharmacology, 1991
- Sex-Related Differences in Drug Disposition in ManClinical Pharmacokinetics, 1984